COMP <GO>
UTMD vs UNH // PIOTROSKI F-SCORE QUALITY
Utah Medical Products Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: UTMD 4
— UNH 6
▲ PIOTROSKI F-SCORE QUALITY LEADER: UNH
LAST: $66.80 (-2.96%) • MKT CAP: $212.7M
piotroski-score
4/9
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UTMD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UTMD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.10% | 88.57% | -31.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.90% | 11.47% | +15.43 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.8x | 16.4x | -5.65 | UTMD | /valuation <GO> |
| Free Cash Flow Yield | 6.73% | 6.48% | +0.25 | UTMD | /fcf-yield <GO> |
| Operating Margin | 29.60% | 4.82% | +24.78 | UTMD | /operating-margins <GO> |
| Net Profit Margin | — | 3.14% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.80% | 6.46% | -12.26 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.87% | 2.28% | -0.41 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.2 | 59.2 | -32.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $212.7M | $368.83B | -$368.62B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UTMD REV | UNH REV | UTMD GROSS % | UNH GROSS % | UTMD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.5M | $447.57B | 57.1% | 88.7% | $14.3M | $16.07B |
| FY 2024 | $40.9M | $400.28B | 59.0% | 88.3% | $14.6M | $20.70B |
| FY 2023 | $50.2M | $371.62B | — | 89.6% | $22.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UTMD // BETA —
UNH // BETA 0.33